Prognostic Factors of Distal Cholangiocarcinoma after Curative Surgery: A Series of 14 Cases

Xinyu Tan,Ke Xiao,Wei Liu,Shi Chang,Tian Zhang,Huihuan Tang
DOI: https://doi.org/10.5754/hge.13212
2013-01-01
Abstract:Background/Aims: The aim of this study was to identify useful prognostic factors for patients with distal cholangiocarcinoma. Methodology: The records of 84 patients with distal cholangiocarcinoma undergoing pancreatoduodenectomy were retrospectively reviewed. Potential clinicopathological prognostic factors that may affect survival were examined by univariate and multivariate analyses. Results: There were two patients died within 30 days of surgery. Overall survival rates were 69.51%, 42.68%, and 36.59% for 1, 3 and 5 years, respectively (median survival time, 32.74 months). Univariate analysis found that alanine aminotransferase/aspartate aminotransferase (AST/ALT) ratio less than and equal to 2, serum bilirubin less than and equal to 171 mu mol/L, CA19-9 level less than 150 U/L, tumor size less than 2 cm, absent neural invasion, and absent lymph node involvement were associated with higher survival rate (p <0.05). Furthermore, multivariate analysis found that AST/ALT ratio more than 2, present lymph node involvement and present neural invasion were the independent risk factors of poor survival (p <0.01). Conclusions: These results suggest that not only the well-known lymph node involvement, but also neural invasion and AST/ALT ratio more than 2 might be useful prognostic factors for long-term survival in distal cholangiocarcinoma.
What problem does this paper attempt to address?